Relevant Weight Reduction and Reversed Metabolic Co-morbidities Can Be Achieved by Duodenojejunal Bypass Liner in Adolescents with Morbid Obesity
- 22 November 2019
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (3) , 1001-1010
Abstract
Duodenojejunal bypass liner (DJBL) is an endoscopic, reversible bariatric procedure resulting in weight loss and metabolic co-morbidities improvements in the adults.Keywords
This publication has 34 references indexed in Scilit:
- Interdisciplinary European Guidelines on Metabolic and Bariatric SurgeryObesity Facts, 2013
- What is metabolic syndrome, and why are children getting it?Annals of the New York Academy of Sciences, 2013
- The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?Pediatric Obesity, 2012
- Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass LinerAnnals of Surgery, 2012
- Nutritional Intake and Prevalence of Nutritional Deficiencies Prior to Surgery in a Spanish Morbidly Obese PopulationObesity Surgery, 2011
- A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric SurgeryAnnals of Surgery, 2010
- Perioperative Safety in the Longitudinal Assessment of Bariatric SurgeryNew England Journal of Medicine, 2009
- First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeveSurgery for Obesity and Related Diseases, 2008
- Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver diseaseClinical Radiology, 1991
- Ultrasound scanning in the detection of hepatic fibrosis and steatosis.BMJ, 1986